Shringar House of Mangalsutra IPO: Analysis, Allotment, and GMP
The Shringar House of Mangalsutra IPO GMP has captivated the market, with its niche focus on a high-demand jewellery segment. As the subscription window closes, investors are now turning their attention to the allotment process and the potential for listing gains, making an understanding of the company's fundamentals and its grey market premium essential.
Shringar House of Mangalsutra: A Deeper Analysis
Shringar House of Mangalsutra specializes in the design, manufacturing, and marketing of mangalsutras, a culturally significant jewellery category in India. The company operates on a business-to-business (B2B) model, supplying to major jewellery retailers like Titan, Malabar Gold, and Reliance Retail.
· Financial Performance: The company has shown strong growth, with revenues increasing to ₹1,429.8 crore in FY25, and net profit nearly doubling to ₹61.1 crore. This robust financial performance highlights its established position and operational efficiency in the market.
· Key Strengths: The company’s strengths include a strong, diversified client base of over 1,000 clients, a diverse product portfolio with over 10,000 designs, and its niche market leadership. It is well-positioned to capitalize on the shift from the unorganized to the organized jewellery sector.
· Risks: Primary risks include a heavy reliance on a single product category and a single manufacturing facility in Mumbai. The business also faces risks from fluctuating gold prices and its dependence on a limited number of major corporate clients.
Understanding the IPO Allotment Process
With the subscription period now over, the focus shifts to the Shringar House of Mangalsutra IPO allotment process.
· Allotment Finalization: The basis of allotment is expected to be finalized on September 15, 2025.
· Demat Credit & Refunds: Shares will be credited to successful applicants' Demat accounts, and refunds for un-allotted shares will be initiated on September 16, 2025.
· How to Check: You can check your allotment status on the registrar's website (MUFG Intime India Private Limited) by entering your PAN or application number. The status will also be available on the BSE website.
Shringar House of Mangalsutra IPO GMP: What the Grey Market Signals
The Shringar House of Mangalsutra IPO GMP has been consistently positive, signaling strong investor confidence. The latest GMP stands at approximately ₹31.
"The gmp indicates a potential listing price of around ₹196 per share (₹165 + ₹31), representing an estimated premium of 18.79% over the issue price. This robust grey market premium suggests a strong and positive debut on the stock exchanges."
Shringar House of Mangalsutra IPO Details at a Glance
· Issue Type: A fresh issue of shares, with a total issue size of ₹400.95 crore.
· Price Band: ₹155 to ₹165 per share.
· Subscription Dates: Open: September 10, 2025; Close: September 12, 2025.
· Lot Size: 90 shares.
· Minimum Retail Investment: ₹14,850.
· Tentative Listing Date: September 17, 2025.
· Listing Platforms: BSE and NSE.
Frequently Asked Questions (FAQs)
1. What is the business model of Shringar House of Mangalsutra? The company specializes in designing and manufacturing mangalsutras and operates primarily on a B2B model, supplying to major jewellers.
2. When can I check my IPO allotment status? The IPO allotment status is expected to be finalized on September 15, 2025, and you can check it on the registrar's website.
3. What is the latest GMP for the IPO? The most recent grey market premium is approximately ₹31, indicating a potential listing price of ₹196.
4. What are the key risks associated with this company? Key risks include a high reliance on a single product category (mangalsutras) and a single manufacturing facility in Mumbai.
5. What is the minimum investment for a retail investor? A retail investor needs to invest a minimum of ₹14,850, which is for one lot of 90 shares.
Disclaimer
The information provided about the Shringar House of Mangalsutra IPO is based on publicly available data. The grey market premium is a speculative figure and should not be considered a guaranteed indicator of listing performance. All investment decisions should be made after consulting with a qualified financial advisor and conducting your own due diligence.
